Demarteau, Nadia <br/><br/>
Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan.  [electronic resource] 

 -  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   
 - 622-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4733 
<br/><br/><label>Standard No.: </label>10.1016/j.jval.2012.02.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Child<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Female<br/>Human papillomavirus 11--immunology<br/>Human papillomavirus 16--immunology<br/>Human papillomavirus 18--immunology<br/>Human papillomavirus 6--immunology<br/>Humans<br/>Markov Chains<br/>Mass Vaccination--economics<br/>Models, Economic<br/>Papillomavirus Infections--economics<br/>Papillomavirus Vaccines--administration & dosage<br/>Quality-Adjusted Life Years<br/>Taiwan--epidemiology<br/>Uterine Cervical Neoplasms--economics<br/>Uterine Cervical Dysplasia--economics